References
- Anderson B O, Bensard D B, Harken A H. The role of platelet activating factor and its antagonists in shock sepsis and multiple organ failure. Surg Gynecol Obstet 1991; 172: 415–24
- Venable M E, Zimmerman G A, Maclntyre T M, Prescott S M. Platelet-activating factor: a phospholipid autocoid with diverse actions. J Lipid Resear 1993; 34: 691–702
- Chao W, Olson M S. Platelet-activating factor: receptors and signal transduction. Biochem J 1993; 292: 617–29
- Nevalainen T J. Review: phospholipase A2 in acute pancreatitis. Scand J Gastroenterol 1988; 23: 897–904
- Bannerjee A K, Galloway S W, Kingsnorth A N. Experimental models of acute pancreatitis. Br J Surg 1994; 81: 1096–1103
- Jaworek K, Konturek S K. Effects of prostaglandins (PG) of E, F and I series, leukotrienes (LT) and platelet-activating factor (PAF) on amylase release from isolated pancreatic acini. Digestion 1992; 52: 92, A
- Emanuelli G, Montruccio G, Gaia E, Dughera L, Corvetti G, Gubetta L. Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol 1989; 134: 315–26
- Yotsumoto F, Manabe T, Kyogoku T, Hirano T, Ohshio G, Yamamoto M, Imamura T, Yoshitomi S. Platelet-activating factor involvement in the aggravation of acute pancreatitis in rabbits. Digestion 1994; 55: 260–7
- Kald B, Kald A, Ihse I, Tagesson C. Release of plateletactivating factor in acute experimental pancreatitis. Pancreas 1993; 8: 440–2
- Ais G, Lopez-Farre A, Gomez-Garre D N, Novo C, Romeo J M, Braquet P, Lopez-Novoa J M. Role of platelet-activating factor in haemodynamic derangements in an acute rodent pancreatic model. Gastroenterology 1992; 102: 181–7
- Jancar S, De Giacobbi G, Mariano M, Mencia-Huerta J, Sirois P, Braquet P. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins 1988; 35: 57–70
- Fujimura K, Kubuta Y, Ogura M, Yamaguchi T, Binaka T, Tani K, Kitagawa S I, Mitzuno E, Inoue K. Role of endogenous platelet-activating factor in caerulein-induced pancreatitis in rats: protective effects of PAF antagonist. J Gastroenterol Hepatol 1992; 7: 199–202
- Tomazewska R, Dembinski A, Warzecha Z, Banas M, Konturek S J, Stachura J. Platelet-activating factor (PAF) inhibitor (TCV-309) reduces caerulein and PAF-induced pancreatitis. A morphologic and functional study in the rat. J Physiol Pharmacol 1992; 4: 345–52
- Whittaker M. PAF-receptor antagonists: recent advances. Curr Opin Therap Patents 1992; 2: 583–623
- Formela L J, Wood L M, Whittaker M, Kingsnorth A N. Amelioration of acute pancreatitis in a rat model by a potent platelet activating factor antagonist. Br J Surg 1994; 81: 1783–5
- Galloway S W, Kingsnorth A N. Acute lung injury in the microembolic model of acute pancreatitis (Abstract). Digestion 1994; 50: 300
- Grino J M. BN 52021. A platelet-activating factor antagonist for preventing post-transplant renal failure: a double-blind, randomized study. Ann Intern Med 1994; 121: 45–7
- Dhainaut J F, Tenaillon A, Le Tulzo Y. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind placebo-controlled, multicentre, clinical trial. Crit Care Med 1994; 22: 720–8
- Bradley E L. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128: 586–90
- Marshall J C. Multiple organ dysfunction syndrome (MODS). Clinical trials for the treatment of sepsis, W J Sibbald, J-L Vincent. Springer-Verlag, New York and London 1995; 122–38
- Kingsnorth A N, Galloway S W, Formela L J. Randomized, double-blind phase II trial of lexipafant, a platelet-activating factor antagonist in human acute pancreatitis. Br J Surg 1995; 82: 1414–20